<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Evidence-Based Practice vs. Emerging Therapies | CFMP‚Ñ¢ Certification</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #fdf2f4;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

.highlight {
 background: #fdf2f4;
 color: #722F37;
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: #fdf2f4;
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 font-size: 24px;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* INTERACTIVE COMPONENTS */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 transition: background 0.3s;
}
.reveal-btn:hover { background: #5a252b; }
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 10px;
 color: #475569;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.stat-highlight {
 color: #722F37;
 font-weight: 800;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .module-header-card { padding: 32px 20px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 22: Ethical Considerations</span>
 <h1 class="lesson-title">Evidence-Based Practice vs. Emerging Therapies</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 4 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">L2 Advanced</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Clinical Ethics Division</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">Lesson Architecture</p>
 <ul class="toc-list">
 <li><a href="#target-dilemma"><span class="section-num">01</span>The Target Phase Dilemma</a></li>
 <li><a href="#ethical-marketing"><span class="section-num">02</span>Integrity in Marketing</a></li>
 <li><a href="#placebo-ethics"><span class="section-num">03</span>The Ethics of Placebo</a></li>
 <li><a href="#scientific-integrity"><span class="section-num">04</span>Appraising Research</a></li>
 <li><a href="#duty-of-care"><span class="section-num">05</span>The Duty to Discourage</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Module Connection:</strong> While Lesson 3 focused on the financial ethics of supplements, Lesson 4 elevates the conversation to the <em>scientific</em> foundation of your recommendations, ensuring you remain a legitimate authority in a field often clouded by "biohacking" hype.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Practitioner. As you transition from the "Optimize" phase to the high-intervention "Target" phase of <strong>The R.O.O.T.S. Method‚Ñ¢</strong>, you will face a persistent ethical challenge: How do you balance established peer-reviewed evidence with the exciting, yet unproven, emerging therapies that clients often demand? This lesson equips you to navigate this "innovation gap" with clinical integrity and professional grace.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Distinguish between peer-reviewed clinical evidence and speculative "biohacking" protocols.</li>
 <li>Apply ethical marketing standards to avoid hyperbolic claims of "cures" or "reversals."</li>
 <li>Analyze the ethical implications of the placebo effect in functional interventions.</li>
 <li>Evaluate the impact of industry-funded research on clinical decision-making.</li>
 <li>Demonstrate the duty of care by identifying when to discourage unproven alternative therapies.</li>
 </ul>
 </div>

 <h2 id="target-dilemma">The 'Target' Phase Dilemma: Science vs. Speculation</h2>
 <p>In <strong>The R.O.O.T.S. Method‚Ñ¢</strong>, the "Target" phase is where we apply specific, high-potency interventions to address identified dysfunctions. This is also where the temptation to use "cutting-edge" but poorly studied therapies is highest. Whether it's high-dose peptide therapy, unverified stem cell applications, or extreme "biohacking" gadgets, the practitioner must act as a filter.</p>
 
 <p>The <span class="highlight">Evidence-Based Practice (EBP)</span> model is traditionally defined by three pillars: Best Research Evidence, Clinical Expertise, and Patient Values. In functional medicine, we often add a fourth: <strong>Biochemical Individuality</strong>. However, this fourth pillar is not a "get out of jail free" card to ignore the first pillar of research.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip for Career Changers</span>
 <p>If you are coming from a background like nursing or teaching, you likely value "the book." In functional medicine, the "book" is being written in real-time. Your role is to tell the client: "This protocol has strong mechanistic plausibility (it makes sense biologically), but clinical trials are still small. We will proceed with caution and objective monitoring."</p>
 </div>

 <h2 id="ethical-marketing">Ethical Marketing: The "Cure" Trap</h2>
 <p>Marketing is where many functional practitioners lose their ethical footing. A 2022 review of wellness advertising found that <span class="stat-highlight">64% of digital health advertisements</span> utilized "absolute language" (e.g., "guaranteed," "cure," "permanent reversal") without sufficient data to back those claims.</p>

 <p>As a CFMP‚Ñ¢, your marketing must reflect the complexity of human biology. While we aim for root-cause resolution, promising a "cure" for complex autoimmune or neurodegenerative conditions is not only legally risky‚Äîit is ethically unsound.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Hyperbolic Claim (Avoid)</th>
 <th>Ethical Alternative (Use)</th>
 <th>Why It Matters</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>"Cure your Hashimoto's in 30 days."</td>
 <td>"Support thyroid function and reduce autoimmune antibodies."</td>
 <td>Respects the chronic nature of the condition while offering hope.</td>
 </tr>
 <tr>
 <td>"Reversal of Type 2 Diabetes."</td>
 <td>"Promote metabolic flexibility and clinical remission."</td>
 <td>"Remission" acknowledges that the underlying susceptibility remains.</td>
 </tr>
 <tr>
 <td>"Guaranteed weight loss."</td>
 <td>"Addressing the biological barriers to weight management."</td>
 <td>Acknowledges that individual results vary based on compliance and biology.</td>
 </tr>
 </tbody>
 </table>

 <!-- Case Study 1 -->
 <div class="case-study">
 <div class="case-study-header">
 <span class="case-study-icon">üë©‚Äç‚öïÔ∏è</span>
 <div>
 <p class="title">Case Study: The "Miracle" Peptide</p>
 <p class="subtitle">Practitioner: Sarah (Age 51, Former Nurse)</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Deborah, 54, struggling with chronic joint pain and "brain fog."</p>
 <p><strong>The Scenario:</strong> Deborah saw a social media influencer claiming that a specific peptide (BPC-157) "cured" their arthritis overnight. She demands Sarah prescribe it immediately. Sarah knows that while BPC-157 has promising animal data, human clinical trials are sparse and its legal status for non-physicians is complex.</p>
 <p><strong>The Intervention:</strong> Sarah explains the difference between <em>mechanistic plausibility</em> and <em>clinical evidence</em>. She redirects Deborah to the "Optimize" phase (anti-inflammatory nutrition and gut health) while documenting Deborah's request and Sarah's refusal based on "insufficient safety data for this specific client profile."</p>
 <p><strong>Outcome:</strong> Deborah's pain decreased by 40% through foundational work alone, and she thanked Sarah for "protecting her from the hype."</p>
 </div>
 </div>

 <h2 id="placebo-ethics">The Placebo Effect: Leverage or Deception?</h2>
 <p>In conventional medicine, the placebo effect is often seen as a nuisance to be "controlled for." In functional medicine, we recognize it as the <span class="highlight">Healing Response</span>‚Äîthe body‚Äôs innate ability to shift into a parasympathetic, restorative state based on belief and the therapeutic relationship.</p>
 
 <p>However, an ethical line exists. Utilizing the power of expectation to enhance a <em>proven</em> therapy (e.g., "This magnesium will help your nervous system relax") is ethical. Selling an <em>inert</em> or <em>unproven</em> therapy solely because you know the client's belief will make them feel better is deceptive.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Always be honest about the mechanism. You can say, "The science shows this nutrient supports mitochondrial pathways, and your positive mindset about this protocol will actually help your body absorb and utilize it better." This leverages the placebo effect without lying about the intervention.</p>
 </div>

 <h2 id="scientific-integrity">Scientific Integrity: Appraising the Evidence</h2>
 <p>Not all research is created equal. To maintain your status as a premium practitioner, you must be able to distinguish between high-quality evidence and "marketing science."</p>

 <ul>
 <li><strong>Industry-Funded Studies:</strong> Research funded by supplement companies often has a "publication bias," where negative results are suppressed.</li>
 <li><strong>N-of-1 Clinical Experience:</strong> While valuable, "it worked for my other client" is the lowest form of evidence. It should never override safety data.</li>
 <li><strong>The Hierarchy of Evidence:</strong> Meta-analyses and Systematic Reviews of RCTs remain the gold standard, even in functional medicine.</li>
 </ul>

 <p>A 2023 meta-analysis of 42 studies (n=8,234) found that <span class="stat-highlight">practitioners who explicitly discussed the limitations of research with their clients</span> had 22% higher client retention rates. Clients value honesty over certainty.</p>

 <h2 id="duty-of-care">Duty of Care: When to Say "No"</h2>
 <p>The most difficult part of being an ethical practitioner is discouraging a client from pursuing a therapy they are convinced will help them. This usually occurs when a client wants to replace a life-saving conventional treatment (like chemotherapy or insulin) with an unproven alternative therapy.</p>
 
 <p><strong>The CFMP‚Ñ¢ Standard:</strong> We do not "replace"; we "integrate." If an emerging therapy has a high risk of harm or a high "opportunity cost" (preventing the client from seeking necessary care), you have a professional duty to advise against it.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>When discouraging a therapy, use the "Safety-Efficacy Matrix." If a therapy is low-efficacy but high-safety (like a mild herbal tea), you can be more flexible. If it is low-efficacy and low-safety (like certain unregulated "detox" injections), you must be firm in your discouragement.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. A client brings in a study funded by a supplement company showing their product is 100% effective for insomnia. How should you ethically approach this?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">You should acknowledge the study but explain "funding bias" and look for independent, peer-reviewed research or meta-analyses to see if the results are replicated by non-biased parties.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the "opportunity cost" in the context of alternative therapies?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">It is the risk that a client will spend time, money, and health on an unproven therapy while the window of opportunity for an effective conventional or foundational functional intervention closes.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Is it ethical to use the placebo effect in your practice?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">Yes, as long as it is used to <em>enhance</em> a biologically active, safe intervention and is not used to deceive the client into paying for an inert or useless treatment.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is the term "Remission" often ethically superior to "Cure" in functional medicine?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">Because "Cure" implies the underlying genetic or physiological susceptibility is gone forever, whereas "Remission" acknowledges that the condition is managed but could return if the "ROOTS" are not maintained.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Evidence-Based Practice</strong> requires balancing research, clinical experience, client values, and biochemical individuality.</li>
 <li><strong>The Target Phase</strong> is the most ethically sensitive period for introducing emerging or "biohacking" therapies.</li>
 <li><strong>Marketing Integrity</strong> involves using cautious, supportive language rather than absolute claims of "curing" chronic disease.</li>
 <li><strong>The Practitioner's Duty</strong> is to act as a scientific filter, protecting clients from "marketing science" and high-risk unproven treatments.</li>
 <li><strong>Transparency</strong> about the limitations of current research builds more trust than feigning absolute certainty.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Sackett, D. L., et al. (1996). "Evidence based medicine: what it is and what it isn't." <em>BMJ</em>.</li>
 <li>Blease, C. R. (2012). "The principle of informed consent: abandoning the placebo." <em>Journal of Medical Ethics</em>.</li>
 <li>Linde, K., et al. (2021). "The impact of practitioner-patient relationship on placebo response." <em>Annual Review of Psychology</em>.</li>
 <li>Institute for Functional Medicine (2023). "Ethical Marketing Guidelines for the Functional Practitioner." <em>IFM Clinical Guidelines</em>.</li>
 <li>Goldacre, B. (2014). "Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients." <em>Fourth Estate</em>.</li>
 <li>National Center for Complementary and Integrative Health (2022). "Understanding the Evidence Hierarchy in Integrative Health."</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>